Background: Melasma is one of the most common causes of facial hyperpigmentation which causes cosmetic disfigurement and leads to psychological proplems, although various treatments are available for melasma, it remains a difficult condition to treat. Aim of Study : To evaluate and compare the efficacy of topical flutamide 1% alone and in-combination with Carboxytherapy in treatment of patients with melasma. Patients and Methods: The study included 30 female patients with different types and patterns of melasma. They were divided into two groups, each group included 15 patients: Group A, patients were treated with 1 % flutamide topical gel on the face and group B, patients were treated with 1 % flutamide topical gel on the face and carboxytherapy injection was done in both sides of the face every four weeks for three sessions. Results: Both groups showed highly significant decrease in mMASI score after the treatment in which group B showed better results with (p-value=0.048*) than group A with (p-value=0. 007*). Conclusion: As new treatment for melasma topical flutamide was effective and safe therapeutic modalities. Carboxytherapy could be effective and safe new treatment modality for melasma as adjuvant treatment with topical flutamide.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.